NCT07198620View on ClinicalTrials.gov

A Real-World Study of IBI351 for KRAS G12C+ NSCLC in China

Not yet recruitingOBSERVATIONAL

Enrollment

600

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

December 1, 2026

Conditions

Lung Cancer (NSCLC)

Trial Locations (1)

510080

Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University,, Guangzhou

All Listed Sponsors

lead

Guangdong Association of Clinical Trials

OTHER

NCT07198620 - A Real-World Study of IBI351 for KRAS G12C+ NSCLC in China | Biotech Hunter | Biotech Hunter